MPR1h
Dapagliflozin Improves Outcomes in HF Patients After Valve Replacement
The DapaTAVI trial assessed the benefits of dapagliflozin in patients discharged after TAVI with a history of heart failure plus 1 of the following comorbidities: LVEF ≤40%, diabetes, or renal ...
MPR1h
Pegcetacoplan Gets Priority Review for Two Rare Kidney Diseases
The supplemental New Drug Application for the C3G and IC-MPGN indications is supported by data from the phase 3 VALIANT study.
MPR3h
FDA Approves Freeze-Dried Formulation of Mpox, Smallpox Vaccine
The live vaccine is produced from the strain Modified Vaccinia Ankara-Bavarian Nordic (MVA-BN), an attenuated, non-replicating orthopoxvirus.
MPR3h
Mixed Results for Solriamfetol in MDD Patients W/Wo Excessive Daytime Sleepiness
Solriamfetol is a dopamine and norepinephrine reuptake inhibitor, trace amine-associated receptor 1 agonist, and 5-HT 1A agonist. It is currently approved under the brand name Sunosi ® to improve ...
MPR4h
Lung Cancer Screening Rates Increased After 2021 Update to USPSTF Guidelines
Lower odds of screening seen in association with lack of health insurance, being rural resident, not having a clinician ...
MPR6h
Weight Loss Greater With Intermittent Fasting Than Calorie Restriction
HealthDay News — An intermittent fasting (IMF) intervention yields modestly greater weight loss than daily caloric restriction (DCR) among adults with overweight or obesity, according to a study ...